Colleen O’Connell

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

Timothy A. Miller, Stephen A. Goutman, N. Staff, 2021, The Lancet Neurology.

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

D. Pitt, M. Racke, A. Boster, 2011, Therapeutic advances in neurological disorders.

MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis

C. O'Connell, P. Morin, F. Cloutier, 2014, Journal of Molecular Neuroscience.

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process

A. Vigano, M. Boivin, E. Eisenberg, 2021, Journal of Cannabis Research.

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate

M. Racke, J. Imitola, A. Boster, 2014, Drug design, development and therapy.

Managing loss of intrathecal baclofen efficacy: Review of the literature and proposed troubleshooting algorithm.

C. Oluigbo, M. Bartoszek, Colleen O’Connell, 2014, Neurology. Clinical practice.